FORMULATION AND EVALUATION OF A MEDICATED ROLL-ON CONTAINING IBUPROFEN AND MAGNESIUM CHLORIDE
DOI:
https://doi.org/10.5281/zenodo.22854313Keywords:
Ibuprofen; Magnesium Chloride; Medicated Roll-On; Topical Drug Delivery; Musculoskeletal Pain; Transdermal Delivery; Formulation and Evaluation; Stability.Abstract
Topical drug delivery has emerged as an effective approach for managing localised pain while minimising the systemic adverse effects associated with oral therapy. This study focuses on the development and evaluation of a medicated roll-on containing ibuprofen and magnesium chloride for the treatment of musculoskeletal pain and inflammation. The formulation was designed using suitable excipients to improve drug solubility, stability, skin compatibility and transdermal penetration. Ibuprofen provides anti-inflammatory and analgesic effects, whereas magnesium chloride promotes muscle relaxation and supports pain relief. The prepared formulation was evaluated for key physicochemical properties, including pH, viscosity, spreadability, drug content, and in vitro drug release. Stability and compatibility studies were also carried out to ensure product quality and performance. The findings indicate that the formulated roll-on is a promising, convenient, and patient-friendly topical system for localised pain management.
References
1. Carragee EJ, et al. “Topical non-steroidal anti-inflammatory drug formulations.” Clin Rheumatol. 2003; 22(2): 123-131.
2. FitzGerald GA, Patrono C. “Ibuprofen: pharmacology, efficacy and safety.” Fundam Clin Pharmacol. 2001; 15(6): 573-586.
3. Williams AC, Barry BW. “Penetration enhancers.” J Controlled Release. 2004; 99(2): 253-275.
4. Brune K, Hinz B. “The discovery and development of anti-inflammatory drugs.” Pharmacol Rev. 2004; 56(1): 1-31.
5. Prausnitz MR, Langer R. “Transdermal drug delivery.” Nat Biotechnol. 2008; 26(11): 1261-1268.
6. Woolf CJ, Thompson SW. “NMDA receptor antagonists and pain.” Pharmacol Rev. 1991; 43(2): 187-238.
7. Rytting JH, Alvarez-Ramos P. “Effect of inorganic salts on Carbopol gels.” Int J Pharm. 1999; 180(2): 155-166.
8. Shinde G, Patil R, Pawar S. “Formulation and evaluation of ibuprofen gel using HPMC/CMC.” Int J Pharm Sci Rev Res. 2022;75(1): 176-181.
9. Aulton ME. Pharmaceutics: The Science Of Dosage Form Design. 3rd Edn; 2007.
10. Hadgraft J, Lane ME. Transdermal Drug Delivery. 2nd Edn; 2016.
11. Sharma P. “Formulation and Evaluation of Topical Ibuprofen Gel.” 2019.
12. Patel RS. “Development and Evaluation of Transdermal Gel Systems.” 2020.
13. Barry BW. “Novel mechanisms and devices to enable successful transdermal drug delivery.” Eur J Pharm Sci. 2001; 14(2): 101-114.
14. Kaur LP, Garg R, Gupta GD. “Development and evaluation of topical gel containing NSAIDs.” Asian J Pharm Clin Res. 2010; 3(3): 45-48.
15. Singh S, Kumar P, Agarwal A. “Development and evaluation of topical gel formulation using HPMC as gelling agent.” Int J Pharm Sci Res. 2014; 5(8): 3376-3382.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Sujal Panchal (Author)
This work is licensed under a Creative Commons Attribution 4.0 International License.
All articles published in ClinSphere Journals are licensed under the Creative Commons Attribution 4.0 International (CC BY 4.0) License.
This license permits unrestricted use, sharing, distribution, reproduction, adaptation, and commercial use of the published work in any medium or format, provided that appropriate credit is given to the original author(s) and the original source, a link to the Creative Commons license is provided, and any changes made are clearly indicated.
Authors retain copyright of their work and grant ClinSphere Journals a non-exclusive license to publish, archive, index, and disseminate the article.
To view a copy of this license, visit:
https://creativecommons.org/licenses/by/4.0/
